Clinical Trials Directory

Trials / Completed

CompletedNCT04929795

Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Dr WANG Shumei · Academic / Other
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to investigate whether a 3-week training program involving music beat (serving as a type of rhythmic auditory stimulation) reduces the severity of bradykinesia and dyskinesia in at-risk individuals and schizophrenia patients. It is hypothesized that the program is effective in reducing the severity of bradykinesia and dyskinesia in at-risk individuals and schizophrenia patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRhythmic auditory stimulation (RAS)The song named 'Sign of The Times' is played and recorded by the research personnel beforehand. The beat of the song will serve as RAS. The computer software "Audacity" will be used to adjust tempi of RAS. Before intervention, the participant is required to execute the movement task without the aid of RAS as quickly as possible for 30 seconds, so that we obtain his/her baseline movement tempo. For each 40-minute training session in the first training week, three RAS tempi will be provided for the first, second, and last 10 minutes with a five-minute break in between: normal (100% of the baseline tempo), quick (105% of the baseline tempo), and fast (110% of the baseline tempo). With each training week, the three RAS tempi will be increased by 5%. Participants in the experimental groups are required to use their right hand to pick up beads from source bowls to the target bowl when listening to the song. The 3-week intervention program will include 21 40-minute daily training sessions.
BEHAVIORALno RASThe training protocol will be the same as that used in the experimental group except the lack of RAS during execution of the movement task.

Timeline

Start date
2021-08-11
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2021-06-18
Last updated
2024-11-21

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04929795. Inclusion in this directory is not an endorsement.